From the Guidelines
Augmentin (amoxicillin-clavulanate) is the preferred choice for treating chest infections in smokers due to its broader spectrum of activity against beta-lactamase producing organisms. The typical adult dosage is 875mg/125mg twice daily or 500mg/125mg three times daily for 7-10 days. Smokers are at higher risk for infections with organisms that produce beta-lactamase enzymes, which can inactivate amoxicillin 1. The clavulanic acid in Augmentin inhibits these beta-lactamase enzymes, making the antibiotic effective against a broader spectrum of bacteria, including Haemophilus influenzae, Moraxella catarrhalis, and some Staphylococcus species that are common in smokers' respiratory infections. Some key points to consider when treating chest infections in smokers include:
- The importance of covering for potential bacterial pathogens, including S. pneumoniae, H. influenzae, M. catarrhalis, and Staph. aureus 1
- The use of a beta-lactamase stable agent, such as co-amoxiclav, as a preferred first choice for non-pneumonic bronchial infections 1
- The consideration of alternative agents, such as macrolides or fluoroquinolones, in certain circumstances, such as intolerance to penicillins or local microbiological surveillance suggesting resistance 1
- The recommendation to complete the full course of antibiotics, even if symptoms improve before finishing treatment, to ensure optimal outcomes and minimize the risk of resistance development. Common side effects of Augmentin include diarrhea, nausea, and rash, and taking the medication with food can help reduce gastrointestinal side effects. Overall, the choice of antibiotic should be guided by the severity of the infection, the presence of comorbidities, and local resistance patterns, with the goal of optimizing outcomes and minimizing morbidity, mortality, and impact on quality of life.
From the FDA Drug Label
Amoxicillin/clavulanic acid has been shown to be active against most isolates of the following bacteria, both in vitro and in clinical infections as described in the INDICATIONS AND USAGE section Gram-positive bacteria Staphylococcus aureus Gram-negative bacteria Enterobacter species Escherichia coli Haemophilus influenzae Klebsiella species Moraxella catarrhalis
The best antibiotic to cover a chest infection in a smoker is Augmentin (amoxicillin-clavulanate), as it has a broader spectrum of activity against both Gram-positive and Gram-negative bacteria, including Haemophilus influenzae and Moraxella catarrhalis, which are commonly found in respiratory tract infections 2.
From the Research
Comparison of Amoxicillin and Augmentin for Chest Infections in Smokers
- Amoxicillin and Augmentin (amoxicillin-clavulanate) are both used to treat bacterial infections, including chest infections in smokers.
- Augmentin is a broad-spectrum antibacterial that has been shown to be effective against a wide range of bacteria, including those that produce beta-lactamases 3, 4.
- Studies have demonstrated that Augmentin is effective against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis, which are common causes of chest infections in smokers 3, 5, 6.
- In a study comparing Augmentin to oxytetracycline for chest infections in general practice, Augmentin was found to be significantly more effective in achieving a good overall response to therapy 7.
- Augmentin has also been shown to be effective in treating lower respiratory tract infections caused by beta-lactamase-positive Haemophilus influenzae and Branhamella catarrhalis 6.
Efficacy of Augmentin Against Specific Bacteria
- Augmentin has been shown to be effective against:
- Augmentin is not effective against all bacteria, including Pseudomonas aeruginosa, which is often resistant to clavulanic acid 4.